ImStar Therapeutics Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
ImStar Therapeutics General Information
Description
Developer of biotechnology-based therapies designed to treat patients with amyotrophic lateral sclerosis disease. The company's therapies are used for the treatment of Alzheimer's, Parkinson's disease, and dementia, enabling healthcare providers to cure diseases of their patients efficiently.
Contact Information
Website
www.imstartx.comCorporate Office
- 1285 West Broadway
- Suite 600
- Vancouver, British Columbia V6H 3X8
- Canada
Corporate Office
- 1285 West Broadway
- Suite 600
- Vancouver, British Columbia V6H 3X8
- Canada
ImStar Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 13-Mar-2025 | Completed | Out of Business | |||
| 4. Later Stage VC | 29-Oct-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 12-Jun-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2014 | $2.3M | $2.3M | Completed | Startup | |
| 1. Seed Round | 01-Sep-2012 | Completed | Startup |
ImStar Therapeutics Comparisons
Industry
Financing
Details
ImStar Therapeutics Competitors (53)
One of ImStar Therapeutics’s 53 competitors is NeuroNascent, a Venture Capital-Backed company based in Clarksville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| ONL Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| Herophilus | Formerly VC-backed | San Francisco, CA |
ImStar Therapeutics Patents
ImStar Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2728870-T3 | Witanolides useful for the treatment of neurodegenerative diseases | Active | 25-Nov-2013 | ||
| AU-2014352629-A1 | Withanolides useful for the treatment of neurodegenerative diseases | Active | 25-Nov-2013 | ||
| AU-2014352629-B2 | Withanolides useful for the treatment of neurodegenerative diseases | Inactive | 25-Nov-2013 | ||
| CA-2931064-A1 | Withanolides useful for the treatment of neurodegenerative diseases | Active | 25-Nov-2013 | ||
| CA-2931064-C | Withanolides useful for the treatment of neurodegenerative diseases | Active | 25-Nov-2013 | C07J71/001 |
ImStar Therapeutics Signals
ImStar Therapeutics FAQs
-
When was ImStar Therapeutics founded?
ImStar Therapeutics was founded in 2012.
-
Where is ImStar Therapeutics headquartered?
ImStar Therapeutics is headquartered in Vancouver, Canada.
-
What is the size of ImStar Therapeutics?
ImStar Therapeutics has 3 total employees.
-
What industry is ImStar Therapeutics in?
ImStar Therapeutics’s primary industry is Biotechnology.
-
Is ImStar Therapeutics a private or public company?
ImStar Therapeutics is a Private company.
-
What is ImStar Therapeutics’s current revenue?
The current revenue for ImStar Therapeutics is .
-
How much funding has ImStar Therapeutics raised over time?
ImStar Therapeutics has raised $4.1M.
-
Who are ImStar Therapeutics’s competitors?
NeuroNascent, Neurona Therapeutics, ONL Therapeutics, CervoMed, and Herophilus are some of the 53 competitors of ImStar Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process